最新の特集記事
Illumina and Microba Life Sciences Partner to Accelerate Microbiome Research
Partnership allows researchers to sequence hundreds of organisms - processing data faster and at larger volumes
特集記事
動画 A Golden Age for China’s NGS Industry
At Illumina’s first NGS Summit in Shanghai, genomics leaders discuss the future of oncology and healthcare
動画 SBS Sequencing Technology Inventors Awarded Millennium Technology Prize
Two University of Cambridge chemists receive one of the world’s highest honors in science and technology
Targeting the Right Drug, at the Right Time, with the Right Dose
Updated array supports clinical researchers that aim to improve medication management and eliminate adverse drug reactions.
Kansas City Lights the Night with a New Research Institute
Genomic sequencing is giving families hope in the face of uncertainty at Children’s Mercy Hospital in Kansas City
Press Releases
In the News
| 日付 | 論文 | タイトル |
|---|---|---|
| 2021/02/25 | BioPharma Reporter | German program using whole genome sequencing to diagnose rare diseases and cancer risk |
| 2021/02/25 | Kaiser Health News | Have a Case of a Covid Variant? No One Is Going to Tell You |
| 2021/02/17 | Cambridge Independent | Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge |
| 2021/02/17 | Bloomberg Technology | Illumina's deSouza on Tech Growth and Need for a Bio Force |
| 2021/02/17 | Associated Press | Government rushes virus gene-mapping as mutations spread |
Additional Resources
Investor Information
Careers at Illumina
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsPress Contacts
If you are a member of the media:
- Email pr@illumina.com
- Tel. 858.882.6822
If you are not a member of the media, please visit Contact Us.